You may have read our post on former NFL player, Jake Plummer, and his mission to bring cannabidiol (CBD) to the NFL. NFL athletes are not the only ones who use CBD to help them heal and recover from the injuries and pain that come with professional sports.
Professional Mixed Martial Arts (MMA) fighter, Nate Diaz, went a full five rounds with featherweight champion, Conor McGregor. Throughout the fight, he suffered brutal blows that left him bruised and swollen. In the press conference after the fight, we see Nate, putting a thin, black pen-shaped object to his mouth and exhaling vapors.
A reporter proceeds to ask him what the object was. Nate tells him it’s a CBD vape pen. He goes on to tell him that he uses it regularly for training and after fights and that it helps with the healing process and inflammation.
CBD has many potential medical properties that may explain why professional athletes, like Nate, uses CBD to help with his healing and recovery process.
- Anti-inflammatory – to help with the swelling and bruising
- Analgesic – to help with the pain from brutal hits and achy muscles
- Antiemetic – to help with the nausea after competition or training
- Neuroprotective – to protect the brain after receiving trauma to the head
However, Nate is facing an investigation by the US Anti-Doping Agency (USADA), who monitors the substances that professional athletes use. Cannabinoids are not permitted according to the World Anti-Doping Agency (WADA) Code which governs USADA. USADA spokesperson Ryan Madden commented “I can confirm that USADA is aware of the situation and is currently gathering information in order to determine the next appropriate steps.”
It will be interesting to see how the USADA handles the situation.
The USADA concluded their investigation on Nate Diaz and his use of a CBD vape pen after his bout against Conor McGregor. They decided to issue him a public warning for admitted use of a prohibited substance. As mentioned in the original post, all cannabinoids are banned substances according to the WADA.